Mono-Therapy versus Poly-Therapy: Ten Years Indian Experience on Various Seizure Disorders

Deepak Goel, Manish Mittal

Department of General Medicine, Swami Ram Himalayan University, Dehradun, India.

DOI: 10.4236/wjns.2015.55034                

Abstract

Objectives: To find out prescription patterns and seizure freedom with different mono-, duo- and poly-therapies used in various seizure disorders in Indian setting. Material and Methods: Subjects with seizures, not responding to first antiepileptic drug, were evaluated prospectively for a period of 6 months. Patients on various dual antiepileptic drugs (AEDs) prescriptions were prospectively analyzed for 1) the pattern and frequency of different duo-therapies; 2) etiological profile of patients in duo-therapy prescription; and 3) frequency of seizure freedom on various duo-therapy groups. Results: Among 2542 patients, 293 (11.5%) lost in follow-up and thus, 2249 (88.5%) were followed. 1324 (58.9%) had seizure freedom on mono-therapy, 532 (23.7%) required duo-therapy and only 45 (2%) were better controlled on poly-therapy. Among the subjects, who were on mono-therapy, Carbamazepine/Oxcarbazepine was the most commonly prescribed in 1285 (50.55%) patients as first drug followed by Valproate compound and Phenytoin. The most common duo-therapy used was combination of Valproate with Lamotregine, followed by Phenytoin and Phenobarbitone. Other mono-therapy and combinations are given in this paper. Conclusions: Duo-therapy was required and found to be effective in 23.7% of Indian patients with epilepsy. Selection of appropriate two drug combination is based on individual approach and overall clinical profile of patient.

Keywords

Antiepileptic Drugs, Refractory Epilepsy, Rationale Poly-Therapy

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Sridharan, R. and Murthy, B.N. (1999) Prevalence and Pattern of Epilepsy in India. Epilepsia, 40, 631-636. http://dx.doi.org/10.1111/j.1528-1157.1999.tb05566.x
[2]	Beghi, E. and Perucca, E. (1995) The Management of Epilepsy in the 1990s: Acquisitions, Uncertainties and Priorities for Future Research. Drugs, 49, 680-694. http://dx.doi.org/10.2165/00003495-199549050-00004
[3]	Perucca, E. (1996) Established Antiepileptic Drugs. Baillieres clin Neurol, 5, 693-722.
[4]	Beghi, E., Di Mascio, R. and Tognoni, G. (1986) Drug Treatment of Epilepsy: Outlines, Criticism and Perspectives. Drugs, 31, 249-265. http://dx.doi.org/10.2165/00003495-198631030-00003
[5]	Schmidt, D. (1982) Two Antiepileptic Drugs for Intractable Epilepsy with Complex-Partial Seizures. Journal of Neurology, Neurosurgery & Psychiatry, 45, 1119-1124. http://dx.doi.org/10.1136/jnnp.45.12.1119
[6]	Brodie, M.J. and Mumford, J.P. (1999) Double-Blind Substitution of Vigabatrin and Valproate in Carbamazepine-Resistant Partial Epilepsy. Epilepsy Research, 34, 199-205. http://dx.doi.org/10.1016/S0920-1211(98)00110-7
[7]	Reynolds, E.H. and Shorvon, S.D. (1981) Monotherapy or Polytherapy for Epilepsy? Epilepsia, 22, 1-10. http://dx.doi.org/10.1111/j.1528-1157.1981.tb04327.x
[8]	Reynolds, E.H. and Shorvon, S.D. (1981) Single Drug or Combination Therapy for Epilepsy? Drugs, 21, 474-482. http://dx.doi.org/10.2165/00003495-198121050-00005
[9]	Birbeck, G.L., Hays, R.D., Cui, X.P. and Vickrey, B.G. (2002) Seizure Reduction and Quality of Life Improvements in People with Epilepsy. Epilepsia, 43, 535-538. http://dx.doi.org/10.1046/j.1528-1157.2002.32201.x
[10]	Collings, J.A. (1990) Epilepsy and Well Being. Social Science & Medicine, 31, 165-170. http://dx.doi.org/10.1016/0277-9536(90)90058-Z
[11]	Leidy, N.K., Elixhauser, A., Vickrey, B., Means, E. and William, M.K. (1999) Seizure Frequency and Health Related Quality of Life of Adults with Epilepsy. Neurology, 53, 162-166. http://dx.doi.org/10.1212/WNL.53.1.162
[12]	Elwes, R.D., Johnson, A.L., Shorvon, S.D., et al. (1984) The Prognosis for Seizure Control in Newly Diagnosed Epilepsy. The New England Journal of Medicine, 311, 944-947. http://dx.doi.org/10.1056/NEJM198410113111503
[13]	Sillanpaa, M., Jalava, M., Kaleva, O., et al. (1998) Long-Term Prognosis of Seizures with Onset in Childhood. The New England Journal of Medicine, 338, 1715-1722. http://dx.doi.org/10.1056/NEJM199806113382402
[14]	Collaborative Group for the Study of Epilepsy (1992) Prognosis of Epilepsy in Newly Referred Patients: A Multicenter Prospective Study of the Effects of Monotherapy on the Long-Term Course of Epilepsy. Epilepsia, 33, 45-51. http://dx.doi.org/10.1111/j.1528-1157.1992.tb02281.x
[15]	Kwan, P. and Brodie, M.J. (2001) Effectiveness of First Antiepileptic Drug. Epilepsia, 42, 1255-1260. http://dx.doi.org/10.1046/j.1528-1157.2001.04501.x
[16]	Lim, S.H., Tan, E.K. and Chen, C. (1997) Pattern of Anti-Epileptic Drug Usage in a Tertiary Referral Hospital in Singapore. Neurological Journal of South East Asia, 2, 77-85.
[17]	Kwan, P. and Brodie, M.J. (2000) Epilepsy after First Drug Fails: Substitution or Add-On? Seizure, 9, 464-468. http://dx.doi.org/10.1053/seiz.2000.0442
[18]	Stephen, L.J. and Brodie, M.J. (2012) Antiepileptic Drugs Monotherapy versus Polytherapy: Pursuing Seizure Freedom and Tolerability in Adults. Current Opinion in Neurology, 25, 164-172. http://dx.doi.org/10.1097/WCO.0b013e328350ba68
[19]	Shorvon, S.D. and Reynolds, E.H. (1979) Reduction in Polytherapy for Epilepsy. BMJ, 2, 1023-1025. http://dx.doi.org/10.1136/bmj.2.6197.1023
[20]	Brodie, M.J. and Graeme, J.S. (2011) Combining Antiepileptic Drugs—Rationale Polytherapy? Seizure, 20, 369-375. http://dx.doi.org/10.1016/j.seizure.2011.01.004
[21]	Hakkarainen, H. (1980) Carbamazepine vs. Diphenylhydantoin vs. Their Combination in Adult Epilepsy. Neurology, 30, 354.
[22]	Stringer, J.L. and Hinggins, M.G. (1994) Interaction of Phenobarbital and Phenytoin in an Experimental Model of Seizures in Rats. Epilepsia, 35, 216-220. http://dx.doi.org/10.1111/j.1528-1157.1994.tb02936.x
[23]	Smith, D.B., Mattson, R.H., Cramer, J.A., Collins, J.F., Novelly, R.A. and Craft, B. (1987) Results of a Nationwide Veterans Administration Co-Operative Study Comparing the Efficacy and Toxicity of Carbamazepine, Phenobarbital, Phenytoin & Primidone. Epilepsia, 28, 550-558. http://dx.doi.org/10.1111/j.1528-1157.1987.tb05778.x
[24]	Kanner, A.M. and Frey, M. (2000) Adding Valproate to Lamotrigine: A Study of Their Pharmacokinetic Interaction. Neurology, 55, 588-591. http://dx.doi.org/10.1212/WNL.55.4.588
[25]	Ghaffapour, M., Hejazie, S.S., Harirchian, M.H. and Pourmahmoodian, H. (2005) Phenytoin, Carbamazepine, Sodium Valproate and Lamotrigine Induced Cutaneous Reactions. Acta Medica Iranica, 43, 37-42.
[26]	Mirelesh, R. and Leppik, E. (2007) Valproate and Clonazepam Comedication in Patients with Intractable Epilepsy. Epilepsia, 26, 122-126. http://dx.doi.org/10.1111/j.1528-1157.1985.tb05394.x
[27]	Nicolson, A., Appleton, R.E., Chadwick, D.W. and Smith, D.F. (2004) The Relationship between Treatment with Valproate, Lamotrigine, and Topiramate and the Prognosis of the Idiopathic Generalised Epilepsies. Journal of Neurology, Neurosurgery & Psychiatry, 75, 75-79.
[28]	Arif, H., Nahm, E.A., Resor Jr., S.R. and Hirsch, L.J. (2008) Efficacy of Clobazam as Add-On Therapy for Refractory Epilepsy: Experience at a US Epilepsy Center. Clinical Neuropharmacology, 31, 333-338. http://dx.doi.org/10.1097/WNF.0b013e31815cd960
[29]	Blaise, F.D. (1986) Bourgeois. Antiepileptic Drug Combinations and Experimental Background: The Case of Phenobarbital and Phenytoin. Archives of Pharmacology, 333, 406-411. http://dx.doi.org/10.1007/BF00500017
[30]	Karas, C.A. (1986) Effects of Phenobarbital in Combination with Phenytoin or Valproic Acid on the Delayed-Matching-to-Sample Performance of Pigeons. Pharmacology Biochemistry and Behavior, 25, 929-932. http://dx.doi.org/10.1016/0091-3057(86)90409-0
[31]	Kostadinova, I., Millusheva, M., Krustev, A. and Toreva, D. (1992) Effects of Phenobarbital, Carbamazepine and a Combination of Both on Corazol-Induced Changes in the Bioelectric Activity of Rat Brains. Folia Medica, 34, 20-23.
[32]	Thomson, A.H. and Brodie, M.J. (1992) Pharmacokinetic Optimization of Anticonvulsant Therapy. Clinical Pharmacokinetics, 23, 216-230. http://dx.doi.org/10.2165/00003088-199223030-00004
[33]	Bourgeois, B.F. (1988) Anticonvulsant Potency and Neurotoxicity of Valproate Alone and in Combination with Carbamazepine or Phenobarbital. Clinical Neuropharmacology, 11, 348-359. http://dx.doi.org/10.1097/00002826-198808000-00003
[34]	Cereghino, J.J., Brock, J.T., Van Meter, J.C., Penry, J.K., Smith, L.D. and White, B.G. (1975) The Efficacy of Carbamazepine Combinations in Epilepsy. Clinical Pharmacology & Therapeutics, 18, 733-741.
[35]	Morris, J.C., Dodson, W.E., Hatlelid, J.M. and Ferrendelli, J.A. (1987) Phenytoin and Carbamazepine, Alone and in Combination Anticonvulsant and Neurotoxic Effects. Neurology, 37, 1111. http://dx.doi.org/10.1212/WNL.37.7.1111